EU drug report warns of rising overdose deaths and surge in new psychoactive substances

The European Union Drugs Agency (EUDA) warned in its annual report that the European drug market is becoming increasingly potent and diverse. At least 7,600 overdose deaths were recorded in 29 European countries—including all 27 EU members, Norway and Turkey—during the last year. The agency noted the appearance of 50 new psychoactive substances in 2025, roughly one new drug each week, and highlighted the spread of synthetic cannabinoids, novel synthetic opioids such as nitazenes and orphans, and growing misuse of ketamine among young people. Cocaine remains widely used, with an estimated 4.3 million European adults aged 15‑64 reporting use in the past year.

In Cyprus, authorities presented parallel findings, noting a sharp rise in cannabis use – 18 % of the general population reported having tried it at least once in 2023, with higher rates among 25‑34‑year‑olds. Eight overdose deaths were recorded in 2024, and seizures of cannabis plant material reached a historic 617 kg. Cocaine and methamphetamine use also increased, with notable concentrations of cocaine detected in wastewater in Larnaca. Cypriot officials warned that users often do not know the exact composition or potency of the substances they consume, heightening health risks.